Ignite Creation Date:
2024-05-06 @ 3:44 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04731740
Status:
WITHDRAWN
Last Update Posted:
2024-03-25
First Post:
2021-01-26
Brief Title:
Pembrolizumab and LenvatinibChemotherapy for Poorly DifferentiatedAnaplastic Thyroid Cancer
Sponsor:
Saint Petersburg State University Russia
Organization:
Saint Petersburg State University Russia
Organization Data
Organization:
Saint Petersburg State University Russia
Class:
OTHER
Study ID:
73
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Saint Petersburg State University Russia
Lead Sponsor Class:
OTHER
Responsible Party:
Efremov Sergey
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Saint Petersburg State University Russia
Old Name:
None
Old Organization:
None